87 related articles for article (PubMed ID: 12568311)
21. Comparison of binding of N3'-->P5' phosphoramidate and phosphorothioate oligonucleotides to cell surface proteins of cultured cells.
Hawley P; Nelson JS; Fearon KL; Zon G; Gibson I
Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):61-9. PubMed ID: 10192290
[TBL] [Abstract][Full Text] [Related]
22. IGF-1 receptor levels and the proliferation of young and senescent human fibroblasts.
Sell C; Ptasznik A; Chang CD; Swantek J; Cristofalo VJ; Baserga R
Biochem Biophys Res Commun; 1993 Jul; 194(1):259-65. PubMed ID: 7687431
[TBL] [Abstract][Full Text] [Related]
23. The effects of antisense insulin-like growth factor-I receptor oligonucleotide on human cord blood lymphocytes.
Yang Y; Niu J; Guo L
J Mol Endocrinol; 2002 Jun; 28(3):207-12. PubMed ID: 12063186
[TBL] [Abstract][Full Text] [Related]
24. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
25. A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.
Coulson JM; Poyner DR; Chantry A; Irwin WJ; Akhtar S
Mol Pharmacol; 1996 Aug; 50(2):314-25. PubMed ID: 8700139
[TBL] [Abstract][Full Text] [Related]
26. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
Li BD; Budnick RM; Russo CA; Anderson GR; Stewart CC
J Surg Res; 1995 Oct; 59(4):485-92. PubMed ID: 7564322
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of hepatocellular carcinoma growth by antisense oligonucleotides to type I insulin-like growth factor receptor in vitro and in an orthotopic model.
Lin RX; Wang ZY; Zhang N; Tuo CW; Liang QD; Sun YN; Wang SQ
Hepatol Res; 2007 May; 37(5):366-75. PubMed ID: 17441810
[TBL] [Abstract][Full Text] [Related]
28. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.
Bergmann U; Funatomi H; Yokoyama M; Beger HG; Korc M
Cancer Res; 1995 May; 55(10):2007-11. PubMed ID: 7743492
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid.
Neuenschwander S; Roberts CT; LeRoith D
Endocrinology; 1995 Oct; 136(10):4298-303. PubMed ID: 7664648
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
Dean N; McKay R; Miraglia L; Howard R; Cooper S; Giddings J; Nicklin P; Meister L; Ziel R; Geiger T; Muller M; Fabbro D
Cancer Res; 1996 Aug; 56(15):3499-507. PubMed ID: 8758918
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.
Pass HI; Mew DJ; Carbone M; Matthews WA; Donington JS; Baserga R; Walker CL; Resnicoff M; Steinberg SM
Cancer Res; 1996 Sep; 56(17):4044-8. PubMed ID: 8752177
[TBL] [Abstract][Full Text] [Related]
33. Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line.
Murphy PR; Sato Y; Knee RS
Mol Endocrinol; 1992 Jun; 6(6):877-84. PubMed ID: 1323055
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1.
Pietrzkowski Z; Mulholland G; Gomella L; Jameson BA; Wernicke D; Baserga R
Cancer Res; 1993 Mar; 53(5):1102-6. PubMed ID: 8439954
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
36. Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer.
Lee CT; Park KH; Adachi Y; Seol JY; Yoo CG; Kim YW; Han SK; Shim YS; Coffee K; Dikov MM; Carbone DP
Cancer Gene Ther; 2003 Jan; 10(1):57-63. PubMed ID: 12489029
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-I (IGF-I) antisense oligodeoxynucleotide mediated inhibition of DNA synthesis by WI-38 cells: evidence for autocrine actions of IGF-I.
Moats-Staats BM; Retsch-Bogart GZ; Price WA; Jarvis HW; D'Ercole AJ; Stiles AD
Mol Endocrinol; 1993 Feb; 7(2):171-80. PubMed ID: 7682287
[TBL] [Abstract][Full Text] [Related]
38. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.
Smetsers TF; Skorski T; van de Locht LT; Wessels HM; Pennings AH; de Witte T; Calabretta B; Mensink EJ
Leukemia; 1994 Jan; 8(1):129-40. PubMed ID: 8289478
[TBL] [Abstract][Full Text] [Related]
39. The IGF-1-IGF-1 receptor system modulates myocyte proliferation but not myocyte cellular hypertrophy in vitro.
Kajstura J; Cheng W; Reiss K; Anversa P
Exp Cell Res; 1994 Dec; 215(2):273-83. PubMed ID: 7982470
[TBL] [Abstract][Full Text] [Related]
40. Autoinduction of platelet derived growth factor (PDGF) A-chain mRNA expression in a human malignant melanoma cell line and growth inhibitory effects of PDGF-A-chain mRNA-specific antisense molecules.
Behl C; Bogdahn U; Winkler J; Apfel R; Brysch W; Schlingensiepen KH
Biochem Biophys Res Commun; 1993 Jun; 193(2):744-51. PubMed ID: 8512572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
